Year in Review Rheumatoid Arthritis

Biosimilar Hyrimoz Gains FDA Approval

The FDA’s approval was supported by data from analytical, preclinical, and clinical research showing that Hyrimoz matched the reference product’s safety, efficacy, and quality.

High Burden of Depression, Anxiety Reported Among Adults With Arthritis

Data from the CDC show that the prevalence of anxiety and depression is higher among adults with arthritis compared with the general population.

TNF-α Inhibitor Therapy May Benefit Extracellular Matrix Remodeling in Women With RA

Anti-TNF-α therapy has a beneficial effect on the metabolism of proteoglycans and glycosaminoglycans tissue in women with rheumatoid arthritis.

Worse Clinical, Ultrasonographic Response in Rheumatoid Arthritis With Obesity

Patients with obesity and rheumatoid arthritis experienced worse clinical and ultrasonographic outcomes.

Sexual Dysfunction Common, Undertreated in Women With Rheumatoid Arthritis

Sexual dysfunction may be common in women with rheumatoid arthritis and affect all subdomains of sexual function.

High Satisfaction With Intravenous Biologic Therapy in Rheumatoid Arthritis

Survey data suggest a high level of satisfaction with intravenous administration of biologic therapy among patients with rheumatoid arthritis.

Comparative Effectiveness of Biologic Agents in Rheumatoid Arthritis Examined

Study results support the recommended use of bDMARDs in combination with csDMARDs in patients with RA.

Higher RA Remission Rates Achieved With Treat-to-Target Strategy vs Routine Care

Higher remission rates and better quality of life were achieved in patients with rheumatoid arthritis who received a treat-to-target strategy.

Many Patients With RA Experience Pain Related to Central Nervous System

Centralized pain pathways may coexist with more established peripheral inflammation-driven pathways in some patients with RA.

Undifferentiated Arthritis: Identifying Candidates for Early Treatment to Prevent Progression to RA

Given the substantial overlap with RA, emerging theories suggest that undifferentiated arthritis represents a unique window of opportunity to intervene in the pathology of RA before it becomes established.